Maculopathy, Age Related (DBCOND0123489)

Identifiers

Synonyms
Maculopathy,Age-related / Age Related Maculopathy / Maculopathies,Age-related / Maculopathies, Age-Related / Age-Related Maculopathies / Maculopathy, Age-Related / Age-Related Maculopathy / Unspecified macular degeneration / Age-Related Macular Degeneration / Age-related macular degeneration (disorder) / Macular degeneration senile / Senile macular degeneration / Macular degeneration (senile) of retina, unspecified

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04129021
Multimodal Ophthalmic ImagingNo drug interventionsotherNot Availableunknown_status
NCT05593913
Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular DegenerationNo drug interventionsNot AvailableNot Availablecompleted
NCT04620876
Bimodal and Coaxial High Resolution Ophtalmic ImagingNo drug interventionsotherNot Availablerecruiting
NCT04128150
High Resolution Retina ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT01494805
Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular DegenerationNo drug interventionstreatment1 / 2completed
NCT01648660
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2)No drug interventionspreventionNot Availablecompleted
NCT00746668
A Multi-Center Study of Reading Rehabilitation in Macular DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00125632
Measuring Reading Rehabilitation OutcomesNo drug interventionsNot AvailableNot Availablecompleted
NCT00763659
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)No drug interventionspreventionNot Availablecompleted
NCT00494325
The Role of Macular Pigment in Patients With Age-related Macular DegenerationNo drug interventionsNot AvailableNot Availablecompleted
NCT01024998
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)No drug interventionstreatment1completed
NCT00051129
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)treatment3completed
NCT00563979
Enhancement of Macular Pigment Density by Oral Lutein SupplementationNo drug interventionspreventionNot Availablecompleted
NCT00877032
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular DegenerationNo drug interventionsprevention1completed
NCT01003691
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic AtrophyNo drug interventionstreatment1completed
NCT00058994
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMDtreatment3completed
NCT00417846
Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)No drug interventionsNot AvailableNot Availablecompleted
NCT00331253
Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).No drug interventionstreatment2unknown_status
NCT00211419
Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)treatment1completed
NCT01122511
Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degenerationtreatment2terminated
NCT00759044
Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier FunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT00474695
Study Evaluating Genotypes Using LucentisNot AvailableNot Availableterminated
NCT01115387
GARM II: A Study on the Genetics of Age-related MaculopathyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05752045
OphtAI Diagnostic Performance Validation for Automated Screening of Eye DiseasesNo drug interventionsscreeningNot Availablerecruiting
NCT00775411
Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)treatment2completed
NCT00473642
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degenerationtreatment4completed
NCT00511706
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)treatment2completed
NCT00460967
Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using RheopheresisNo drug interventionstreatment3suspended
NCT01577381
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular DegenerationNo drug interventionstreatment2terminated
NCT00056823
Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)treatment1 / 2completed